VT News

Jasir Asani

Ask VT AI
View News Summary
  • Novartis to acquire US biotech Tourmaline Bio for $1.4B, bolstering its cardiovascular pipeline with a promising anti-inflammatory drug candidate.
  • The Rock transforms for eccentric film role, losing 30 pounds of muscle, sparking speculation about his future in wrestling.
  • Core & Main reports strong Q2 results, but cuts full-year outlook due to higher costs and weaker residential demand.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Novartis to acquire US biotech Tourmaline Bio for $1.4B, bolstering its cardiovascular pipeline with a promising anti-inflammatory drug candidate.
  • The Rock transforms for eccentric film role, losing 30 pounds of muscle, sparking speculation about his future in wrestling.
  • Core & Main reports strong Q2 results, but cuts full-year outlook due to higher costs and weaker residential demand.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Jasir Asani

Top Topics

Trending in U.S.

World

Sport